As the second Part of the WHINN TECH Talks, CEREBRIU’s CEO Robert Lauritzen talks about how Apollo helps to save time, optimize resources and target the treatment
Cerebriu can be seen featured in the Health Europa Quarterly Issue 15 The article about the role of MRI in stroke care can be found
Cerebriu’s role of MRI in stroke care is featured today in this Health Europa article. “Today’s time to treatment for an acute stroke is too
Cerebriu has raised a two million euros seed round to support R&D, international clinical trials, and initial implementation at hospitals. Investors include KMD Venture, Crista
CEREBRIU supports the Ten Principles of the United Nations Global Compact on human rights, labour, environment and anti-corruption. With this communication, we express our intent
Eurostars Apollo consortia agreement signed between Oslo University Hospital, Herlev and Gentofte Hospital, University of Copenhagen and Cerebriu. Apollo installation and initial retrospective clinical validation
Cerebriu’s CE approved product Apollo was featured heavily in this Health Europa article focusing on our aims to scale up clinical support through faster personalised
Cerebriu receives millions in funding from the Innovation Fund Denmark to develop health technology for identifying which COVID-19 patients will need intensive care. The technology
Texture analysis could help quantifying COPD on CT A Scientific paper co-authored by our own Senior researcher and PhD. of the University of Copenhagen, Lauge Sørensen, has been
Hospitals are under unprecedented pressure to accurately monitor disease progression and predict which COVID-19 patients needing ICU support. University of Copenhagen, and Copenhagen University Hospital
Cerebriu announced as 1st place of Top 3 Winners of the RESI Europe innovation challenge, after the conclusion of the 3 day RESI Europe event.
Cerebriu was mentioned by Health Europe, today on the 26th of March. The site Introduced and accounted for how Cerebriu strives to improve workflow efficiency,